Detecting low-abundance vasoactive peptides in plasma: Progress toward absolute quantitation using nano liquid chromatography-mass spectrometry

Analytical Biochemistry

Volumn 394, Issue 2, 2009, Pages 164-170

  Lortie, Mark ^a,b,c   Bark, Steven ^d   Blantz, Roland ^a,b,c   Hook, Vivian ^a,d,e  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

ACEi; Angiotensin; Bradykinin; Nonspecific adsorption; Quantitative MS; Vasoactive peptides

Indexed keywords

DISEASE CONTROL; DRUG INFUSION; ENDOCRINOLOGY; ENZYME INHIBITION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HORMONES; LIQUIDS; MASS SPECTROMETRY;

ACEI; ANGIOTENSIN; BRADYKININ; NONSPECIFIC ADSORPTION; QUANTITATIVE MS;

PEPTIDES;

ANGIOTENSIN; ANGIOTENSIN II; BRADYKININ; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; METHANOL; PEPTIDE HORMONE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD LEVEL; BLOOD SAMPLING; CONTROLLED STUDY; DRUG INFUSION; ENZYME INHIBITION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; NONHUMAN; PRECIPITATION; PRIORITY JOURNAL; PROTEIN PURIFICATION; RAT; RODENT; SENSITIVITY AND SPECIFICITY;

RATTUS; RODENTIA;

EID: 69949095688     PISSN: 00032697     EISSN: 10960309     Source Type: Journal    
DOI: 10.1016/j.ab.2009.07.021     Document Type: Article

References (34)

1. Duncia J.V., Carini D.J., Chiu A.T., Johnson A.L., Price W.A., Wong P.C., Wexler R.R., and Timmermans P.B. The discovery of DuP 753, a potent, orally active nonpeptide angiotensin II receptor antagonist. Med. Res. Rev. 12 (1992) 149-191
2. Pesaturo A.B., Jennings H.R., and Voils S.A. Terlipressin: vasopressin analog and novel drug for septic shock. Ann. Pharmacother. 40 (2006) 2170-2177
3. Delmas A., Leone M., Rousseau S., Albanese J., and Martin C. Clinical review: vasopressin and terlipressin in septic shock patients. Crit. Care 9 (2005) 212-222
4. Weber M.A. New opportunities in cardiovascular patient management: a survey of clinical data on the combination of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers. Am. J. Cardiol. 100 (2007) S45
5. Allikmets K. Aliskiren-an orally active renin inhibitor: review of pharmacology, pharmacodynamics, kinetics, and clinical potential in the treatment of hypertension. Vasc. Health Risk Manag. 3 (2007) 809-815
6. Molinaro G., Rouleau J.-L., and Adam A. Vasopeptidase inhibitors: a new class of dual zinc metallopeptidase inhibitors for cardiorenal therapeutics. Curr. Opin. Pharmacol. 2 (2002) 131
7. Ardaillou R. Active fragments of angiotensin II: enzymatic pathways of synthesis and biological effects. Curr. Opin. Nephrol. Hypertens. 6 (1997) 28-34
8. Blais C., Marceau F., Rouleau J.-L., and Adam A. The kallikrein-kininogen-kinin system: lessons from the quantification of endogenous kinins. Peptides 21 (2000) 1903-1940
9. Chappell M.C., Pirro N.T., Sykes A., and Ferrario C.M. Metabolism of angiotensin-(1-7) by angiotensin-converting enzyme. Hypertension 31 (1998) 362-367
10. Gauthier K.M., Zhang D.X., Cui L., Nithipatikom K., and Campbell W.B. Angiotensin II relaxations of bovine adrenal cortical arteries: role of angiotensin II metabolites and endothelial nitric oxide. Hypertension 52 (2008) 150-155
11. Greco A.J., Master R.G., Fokin Jr. A., Baber S.R., and Kadowitz P.J. Angiotensin-(1-7) potentiates responses to bradykinin but does not change responses to angiotensin I. Can. J. Physiol. Pharmacol. 84 (2006) 1163-1175
12. Lortie M., Regoli D., Rhaleb N.E., and Plante G.E. The role of B1- and B2-kinin receptors in the renal tubular and hemodynamic response to bradykinin. Am. J. Physiol. 262 (1992) R72-R76
13. Santos R.A.S., Campagnole-Santos M.J., and Andrade S.P. Angiotensin-(1-7): an update. Regul. Pept. 91 (2000) 45-62
14. Casarini D.E., Boim M.A., Stella R.C., and Schor N. Endopeptidases (kininases) are able to hydrolyze kinins in tubular fluid along the rat nephron. Am. J. Physiol. 277 (1999) F66-F74
15. Nussberger J., Cugno M., Amstutz C., Cicardi M., Pellacani A., and Agostoni A. Plasma bradykinin in angio-oedema. Lancet 351 (1998) 1693-1697
16. Skidgel R.A., and Erdos E.G. Novel activity of human angiotensin I converting enzyme: release of the NH2- and COOH-terminal tripeptides from the luteinizing hormone-releasing hormone. Proc. Natl. Acad. Sci. USA 82 (1985) 1025-1029
17. Vickers C., Hales P., Kaushik V., Dick L., Gavin J., Tang J., Godbout K., Parsons T., Baronas E., Hsieh F., Acton S., Patane M., Nichols A., and Tummino P. Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase. J. Biol. Chem. 277 (2002) 14838-14843
18. De Silva P.E., Husain A., Smeby R.R., and Khairallah P.A. Measurement of immunoreactive angiotensin peptides in rat tissues: some pitfalls in angiotensin II analysis. Anal. Biochem. 174 (1988) 80-87
19. Nussberger J., Brunner D.B., Waeber B., and Brunner H.R. True versus immunoreactive angiotensin II in human plasma. Hypertension 7 (1985) I1-I7
20. Voelker J.R., Cobb S.L., and Bowsher R.R. Improved HPLC-radioimmunoassay for quantifying angiotensin II in plasma. Clin. Chem. 40 (1994) 1537-1543
21. Bragat A.C., Blumenfeld J., and Sealey J.E. Effect of high-performance liquid chromatography on plasma angiotensin II measurements in treated and untreated normotensive and hypertensive patients. J. Hypertens. 15 (1997) 459-465
22. Tamvakopoulos C. Mass spectrometry for the quantification of bioactive peptides in biological fluids. Mass Spectrom. Rev. 26 (2007) 389-402
23. Venable J.D., Dong M.Q., Wohlschlegel J., Dillin A., and Yates J.R. Automated approach for quantitative analysis of complex peptide mixtures from tandem mass spectra. Nat. Methods 1 (2004) 39-45
24. Govorukhina N.I., Reijmers T.H., Nyangoma S.O., van der Zee A.G.J., Jansen R.C., and Bischoff R. Analysis of human serum by liquid chromatography-mass spectrometry: improved sample preparation and data analysis. J. Chromatogr. A 1120 (2006) 142-150
25. Kay R.G., Gregory B., Grace P.B., and Pleasance S. The application of ultra-performance liquid chromatography/tandem mass spectrometry to the detection and quantitation of apolipoproteins in human serum. Rapid Commun. Mass Spectrom. 21 (2007) 2585-2593
26. Cui L., Nithipatikom K., and Campbell W.B. Simultaneous analysis of angiotensin peptides by LC-MS and LC-MS/MS: metabolism by bovine adrenal endothelial cells. Anal. Biochem. 369 (2007) 27-33
27. Martosella J., Zolotarjova N., Liu H., Nicol G., and Boyes B.E. Reversed-phase high-performance liquid chromatographic prefractionation of immunodepleted human serum proteins to enhance mass spectrometry identification of lower-abundant proteins. J. Proteome Res. 4 (2005) 1522-1537
28. Lortie M.J., Ishizuka S., Schwartz D., and Blantz R.C. Bioactive products of arginine in sepsis: tissue and plasma composition after LPS and iNOS blockade. Am. J. Physiol. Cell Physiol. 278 (2000) C1191-C1199
29. Lortie M.J., Satriano J., Gabbai F.B., Thareau S., Khang S., Deng A., Pizzo D.P., Thomson S.C., Blantz R.C., and Munger K.A. Production of arginine by the kidney is impaired in a model of sepsis: early events following LPS. Am. J. Physiol. Regul. Integr. Comp. Physiol. 287 (2004) R1434-R1440
30. Munger K.A., Blantz R.C., and Lortie M.J. Acute renal response to LPS: impaired arginine production and inducible nitric oxide synthase activity. Am. J. Physiol. Regul. Integr. Comp. Physiol. 291 (2006) R684-R691
31. Want E.J., O'Maille G., Smith C.A., Brandon T.R., Uritboonthai W., Qin C., Trauger S.A., and Siuzdak G. Solvent-dependent metabolite distribution, clustering, and protein extraction for serum profiling with mass spectrometry. Anal. Chem. 78 (2006) 743-752
32. van Midwoud P.M., Rieux L., Bischoff R., Verpoorte E., and Niederlander H.A. Improvement of recovery and repeatability in liquid chromatography-mass spectrometry analysis of peptides. J. Proteome Res. 6 (2007) 781-791
33. Bark S.J., and Hook V. Differential recovery of peptides from sample tubes and the reproducibility of quantitative proteomic data. J. Proteome Res. 6 (2007) 4511-4516
34. Tom B., Dendorfer A., and Jan Danser A.H. Bradykinin, angiotensin-(1-7), and ACE inhibitors: how do they interact?. Intl. J. Biochem. Cell Biol. 35 (2003) 792-801